These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2172264)

  • 21. The effect of cyclodextrin on lipopolysaccharide production in cultures of Bordetella pertussis.
    Ibsen P; Schou C; Au-Jensen M; Heron I
    J Biol Stand; 1989 Oct; 17(4):321-30. PubMed ID: 2559082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines.
    Barkoff AM; Guiso N; Guillot S; Xing D; Markey K; Berbers G; Mertsola J; He Q
    J Immunol Methods; 2014 Jun; 408():142-8. PubMed ID: 24925807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single radial immunodiffusion as a method for the assay of the acellular pertussis vaccine components, pertussis toxoid, filamentous haemagglutinin and pertactin.
    Xing DK; Canthaboo C; Corbel MJ; Schild GC
    Biologicals; 1998 Sep; 26(3):217-24. PubMed ID: 10208723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial growth and virulence factors production by different Bordetella pertussis strains.
    Letowska I; Chodorowska M; Kaczurba E; Kuklińska D; Tyski S
    Acta Microbiol Pol; 1997; 46(1):45-55. PubMed ID: 9271847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
    Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
    Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of Bordetella pertussis virulence components with neutrophils: effect on chemiluminescence induced by a chemotactic peptide and by intact bacteria.
    Craig FF; Lackie JM; Parton R; Freer JH
    J Gen Microbiol; 1988 Aug; 134(8):2201-11. PubMed ID: 2908118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering bacterial toxin for the development of new vaccine against pertussis.
    Bartoloni A; Pizza M; Gross R; Perugini M; Arico B; Domenighini M; Rappuoli R
    Tokai J Exp Clin Med; 1988; 13 Suppl():217-22. PubMed ID: 2483870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The location of filamentous hemagglutinin and pertussis toxin antigens of Bordetella pertussis by immunoelectron microscopy.
    Watanabe H; Kanesaki S; Shukuda Y; Mayahara H
    J Electron Microsc (Tokyo); 1989; 38(3):172-81. PubMed ID: 2549145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does whole-cell pertussis vaccine protect black South African infants? Assessment of post-vaccination events and antibody responses to pertussis toxin, filamentous haemagglutinin and agglutinogens 2 and 3.
    Ramkissoon A; Coovadia HM; Loening WE; Ndlovana M
    S Afr Med J; 1991 Jun; 79(11):645-9. PubMed ID: 1675492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physico-chemical analysis of Bordetella pertussis antigens.
    Bolgiano B; Crane DT; Xing D; Williams L; Jones C; Corbel MJ
    Biologicals; 1999 Jun; 27(2):155-62. PubMed ID: 10600205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-step purification of pertussis toxin and its subunits by heat-treated fetuin-sepharose affinity chromatography.
    Chong P; Klein M
    Biochem Cell Biol; 1989 Jul; 67(7):387-91. PubMed ID: 2477043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissecting human T cell responses against Bordetella species.
    De Magistris MT; Romano M; Nuti S; Rappuoli R; Tagliabue A
    J Exp Med; 1988 Oct; 168(4):1351-62. PubMed ID: 2902185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
    Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
    Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of pertussis toxin in an enzyme linked immunosorbent assay with improved specificity.
    Ibsen P; Heron I
    Biologicals; 1990 Apr; 18(2):123-6. PubMed ID: 2375859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin.
    Menozzi FD; Gantiez C; Locht C
    FEMS Microbiol Lett; 1991 Feb; 78(1):59-64. PubMed ID: 2032624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and partial characterization of filamentous haemagglutinin from Bordetella pertussis using monoclonal antibodies.
    Selmer JC; Larsen FS; Hertz JB; Parton R
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):279-84. PubMed ID: 6097092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin.
    Ginnaga A; Morokuma K; Aihara K; Sakou M; Imaizumi A; Suzuki Y; Sato H; Sato Y; Ueda K; Kuno-Sakai H
    Tokai J Exp Clin Med; 1988; 13 Suppl():59-69. PubMed ID: 2908528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers.
    Sato Y; Sato H
    Tokai J Exp Clin Med; 1988; 13 Suppl():79-88. PubMed ID: 2908530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
    Thomas MG; Ashworth LA; Miller E; Lambert HP
    J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.